Apeloa Honored with Frost & Sullivan’s 2026 Global CDMO Company of the Year Award
Global GIL Recognition Spotlights Apeloa’s End-to-End “API + Drug Product” Integration, Advanced Technology Platforms, and Its Compliance Track Record in Regulated Markets SHANGHAI — Apeloa Pharmaceutical Co., Ltd. (Apeloa; SZSE:…